SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

$4CHAN is trending as community members highlight its potential as the 'Bitcoin of memecoins,' emphasizing its origin within internet culture and its strong community. Talk centers around the token's potential for significant growth and its unique characteristics, such as its tokenomics. Some users suggest that $4CHAN can lead the meme sector.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as the community discusses its high throughput and compliance-ready design, positioning it as a key infrastructure player for institutional finance. Community members are comparing it favorably to established projects, noting its focus on regulatory needs and its ability to handle millions of transactions per second. The recent integration with Bridge, a Stripe company, further amplifies Keeta's potential by providing seamless fiat on-ramps.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnight ($NIGHT) is trending as the privacy-focused blockchain gains attention within the Cardano ($ADA) ecosystem, with discussions around its potential and recent price volatility. Community members are actively discussing airdrop claims, exchange availability, and overall utility, while some express skepticism and caution due to past events associated with figures involved.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending amid excitement surrounding a potential SpaceX IPO, which is boosting interest in the broader space sector. Community members are discussing Rocket Lab's potential as a competitor and the possibility of new contracts. Recent launch successes and progress with the Neutron rocket are also fueling positive sentiment.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as the community discusses the potential impact of stricter FDA vaccine regulations and a leaked memo linking COVID shots to child deaths, with concern that NVAX is being unfairly grouped with mRNA vaccines despite its different technology and lack of approval for young children.  Shareholders are frustrated by the company's silence on these issues and the perceived lack of leadership, prompting calls for a change in management. Some speculate about potential acquisition scenarios and the value of Novavax's Matrix-M adjuvant in a changing vaccine landscape.

Ambiq Micro, Inc. engages in the provision of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI computing. It operates through the following geographical segments: China, Taiwan, Singapore, and Rest of the World. The company was founded by Scott Hanson, Dennis Sylvester, and David Blaauw on January 20, 2010 and is headquartered in Austin, TX.

Ambiq Micro Inc.

Ambiq Micro, Inc.

Ambiq Micro ($AMBQ) is trending amid community excitement and speculation, particularly around its potential in edge AI and wearable tech, fueled by whispers of new deals and partnerships. The company's upcoming presentations and potential applications in devices like the Oura Ring are key talking points. Investor sentiment appears mixed, ranging from bullish excitement about long-term potential to concerns about profitability and leadership.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess the volatile semiconductor sector following recent market fluctuations and a steep decline. Community members are actively discussing dip-buying opportunities and potential for a rebound, while also weighing bearish signals and the possibility of further drops. News regarding NVIDIA's chip sales and Evercore's price target are adding to the conversation.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors await the 48-week data release and potential FDA feedback, with discussions focusing on trial design and data interpretation. Community members are debating the implications of past data disclosures and the company's future prospects, with some expressing concerns about trial outcomes. The new CEO's background and potential for strategic partnerships are also key talking points.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

$VNDA is trending as upcoming PDUFA dates and potential catalysts spark renewed interest and optimism among investors, with some anticipating a potential buyout. The community is closely watching for positive news, particularly regarding Tradipitant, and believe the stock is undervalued given its cash position and pipeline. Discussions also revolve around management's strategy and marketing spend.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

Despite strong Q2 results and a new buyback program, ABNB is trending due to concerns about its Q3 guidance, with discussions centering on slowing growth and margin pressure. Community members are debating the company's valuation and long-term potential, as well as new services and experiences. Some investors believe ABNB is undervalued, while others express concerns about its growth prospects and competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OPKO Health (NASDAQ:OPK) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded OPKO Health from a "hold" rating to a "sell" rating in a research note on Saturday...

Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now

OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.

OPKO Health, Inc. (NASDAQ:OPK) Given Average Rating of "Hold" by Brokerages

Shares of OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) have been assigned a consensus rating of "Hold" from the seven brokerages that are covering the company, Marketbeat Ratings reports. One...

OPKO Health (NASDAQ:OPK) CEO Acquires $771,400.00 in Stock

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 580,000 shares of OPKO Health stock in a transaction dated Friday, November 21st. The shares were bought at an...

Zacks Research Boosts Earnings Estimates for OPKO Health

OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Research analysts at Zacks Research lifted their FY2025 earnings estimates for OPKO Health in a research report issued on Wednesday, November 19th...

OPKO Health (NASDAQ:OPK) Earns Neutral Rating from Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. assumed coverage on shares of OPKO Health in a research report on Thursday. They set a "neutral" rating for the company...

OPKO Health (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 580,000 Shares

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 580,000 shares of OPKO Health stock in a transaction that occurred on Wednesday, November 19th. The stock was...

Phillip Md Et Al Frost Purchases 533,300 Shares of OPKO Health (NASDAQ:OPK) Stock

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 533,300 shares of the business's stock in a transaction dated Tuesday, November 18th. The stock was acquired at an...

Phillip Md Et Al Frost Acquires 533,300 Shares of OPKO Health (NASDAQ:OPK) Stock

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 533,300 shares of OPKO Health stock in a transaction dated Tuesday, November 18th. The stock was bought at an...

OPKO Health, Inc. $OPK Shares Sold by Y.D. More Investments Ltd

Y.D. More Investments Ltd reduced its position in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 13.8% in the 2nd quarter, according to the company in its most recent 13F filing with the...

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

OPK
Opko Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OPK News

OPKOpko Health Inc